NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma.

Kang-Shuai Li, Xiao-Dong Zhu, Hong-Da Liu, Shi-Zhe Zhang, Xiao-Long Li, Nan Xiao, Xue-Feng Liu, Bin Xu, Ming Lei, Yuan-Yuan Zhang, Wen-Kai Shi, Man-Qing Cao, Yun-Fei Xu, Zhao-You Tang, Hui-Chuan Sun

Cell death & disease 2020 May 07

filter terms:

Most hepatocellular carcinoma (HCC) patients are diagnosed at an advanced stage; however, the effect of systemic therapy on advanced HCC remains undetermined. Therefore, new treatment targets must be identified. We analyzed Gene Expression Omnibus datasets from two HCC patient cohorts and found that NT5DC2 was associated with vascular invasion and poor survival. In two hepatoma cell lines, NT5DC2 overexpression promoted HCC cell proliferation and clone formation in vitro and promoted tumor growth in vivo. Coimmunoprecipitation assays and liquid chromatography with tandem mass spectrometry analysis revealed that NT5DC2 bound directly to epidermal growth factor receptor (EGFR). NT5DC2 upregulated EGFR expression by downregulating EGFR ubiquitination and preventing its degradation via the ubiquitin-proteasome pathway but did not upregulate its transcription. EGFR upregulation activated downstream signal transduction, which played a critical role in the protumor effects of NT5DC2. Erlotinib, a small-molecule inhibitor of EGFR, blocked the effect of NT5DC2 in promoting HCC cell proliferation. In a cohort of 79 patients who underwent curative resection for HCC, NT5DC2 expression in the tumors was associated with larger tumors and microvascular invasion. NT5DC2 expression was also independently associated with recurrence-free survival. The present study demonstrated for the first time that NT5DC2 promotes tumor cell proliferation in HCC and may serve as a potential molecular target for treating HCC. EGFR blockage could be used to treat selected patients with NT5DC2 upregulation.

Citation

Kang-Shuai Li, Xiao-Dong Zhu, Hong-Da Liu, Shi-Zhe Zhang, Xiao-Long Li, Nan Xiao, Xue-Feng Liu, Bin Xu, Ming Lei, Yuan-Yuan Zhang, Wen-Kai Shi, Man-Qing Cao, Yun-Fei Xu, Zhao-You Tang, Hui-Chuan Sun. NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma. Cell death & disease. 2020 May 07;11(5):335